In 2023, Stanley M. Bergman earned $2.61M in total compensation at Henry Schein, including $1.63M salary and $643.65K bonus. Most recently acquired 308,739 shares in Mar 2025. Currently holds stock worth $130.33M. Has donated $68.32M in stock to charitable causes. Led Henry Schein as CEO for 5 years.
Compensation History
Annual executive compensation data for Stanley M. Bergman, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$2.61M
Salary
$1.63M
Bonus
$643.65K
Other
$341.74K
Salary
$1.63MBoard Justification
The compensation philosophy is designed to attract and retain top talent while aligning executive compensation with the company's performance and strategic goals.
Bonus
$643.65KBoard Justification
Based on 2023 achievement levels (0% for the 2023 Company Financial/EPS Goal and 87% for the Strategic Scorecard Goals)
Other Compensation
$341.74KBoard Justification
Includes matching contributions under the 401(k) Plan, excess life insurance premiums, SERP contributions, and other benefits
Restricted Stock
Board Justification
No stock grants vested in 2023, only the stock that is already vested is included
Performance Metrics
The performance metrics for 2023 included adjusted EPS and strategic scorecard goals.
Stanley M. Bergman
Ex-CEO of Henry Schein
Education
Bachelor's degree from the University of Cape Town; MBA from the Wharton School of the University of Pennsylvania
Field of Expertise
Healthcare & Life Sciences - Healthcare
Sector of Economy
Healthcare
Born
February 6, 1955 - 70 years ago
CEO of Henry Schein for
5 years 10 months (Dec 2016 - Nov 2022)
Previous Experience
Chairman and Chief Executive Officer of Henry Schein, Inc.
Holdings
Track Stanley M. Bergman's stock holdings and portfolio value over time.
Total Stock Sold
$95.44M
$95.44M
1,196,144.6 HSIC shares
What if they kept their stock?
If Stanley M. Bergman didn't sell their stock, today they would have:
Extra HSIC1,196,144.6 shares worth $87.47M.
This is -8.34% and $7.96M less than what they got when they sold the stock.
Charitable Transactions
934,252.375 shares
HSIC
Recent Charitable Transactions
3,800 shares
HSIC
Mar 12, 2025
Charity
6,071 shares
HSIC
Dec 11, 2024
Charity
634 shares
HSIC
Sep 16, 2024
Charity
1,560 shares
HSIC
Aug 12, 2024
Charity
1,119 shares
HSIC
May 14, 2024
Charity
475 shares
HSIC
Mar 20, 2024
Charity
Insider Trading
Stanley M. Bergman's recent stock transactions, purchases, and sales filed with the SEC.
3,800 shares
HSIC
Mar 12, 2025
Charity
308,739 shares
HSIC
Mar 10, 2025
Received
6,071 shares
HSIC
Dec 11, 2024
Charity
634 shares
HSIC
Sep 16, 2024
Charity
1,560 shares
HSIC
Aug 12, 2024
Charity
1,119 shares
HSIC
May 14, 2024
Charity
475 shares
HSIC
Mar 20, 2024
Charity
460 shares
HSIC
Mar 6, 2024
Charity
101,117 shares
HSIC
Mar 1, 2024
Received
$4.27M
HSIC at $75.09/share
Dec 22, 2023
Sale
Rivals
Compare Stanley M. Bergman with competitor CEOs and industry peers.
Albert G. White, III
CEO of The Cooper Companies, Inc.
2023 Compensation
Stock
$5.00M
Salary
$1.08M
Bonus
$1.84M
Other
$16.05K
Total Holdings
$68.53M
Darcy H. Davenport
CEO of BellRing Brands
2023 Compensation
Stock
$0.00
Salary
$700.00K
Bonus
$875.00K
Other
$47.34K
Total Holdings
$16.14M
Eric M. Green
CEO of West Pharmaceutical Services
2023 Compensation
Stock
$0.00
Salary
$1.14M
Bonus
$1.67M
Other
$92.48K
Total Holdings
$159.06M
Fred P. Lampropoulos
Founder and CEO of Merit Medical Systems
2023 Compensation
Stock
$2.77M
Salary
$1.89M
Bonus
$1.34M
Other
$8.70K
Total Holdings
$38.99M